Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall E Harris

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Oncology Reports|June 18, 2002
Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokersRandall E Harris, Joanne Beebe-Donk, Hildegard M Schuller
World Journal of Clinical Oncology|October 11, 2014
Cyclooxygenase-2 and the inflammogenesis of breast cancerRandall E Harris, Bruce C Casto, Zachary M Harris
Frontiers in Oncology|January 22, 2026
Vaping, smoking and risk of early onset lung cancerMarisa A Bittoni, David P Carbone, Randall E Harris
International Journal of Biological Sciences|June 26, 2007
Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
BMC Cancer|August 16, 2008
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
Sub-Cellular Biochemistry|July 7, 2007
Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studiesRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
Oncology Reports|March 10, 2005
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)Randall E Harris, Joanne Beebe-Donk, Hani Doss, et al.
Infection Control and Hospital Epidemiology|July 14, 2009
Colonization with Staphylococcus aureus and methicillin-resistant S. aureus among a sample of homeless individuals, OhioTimothy F Landers, Randall E Harris, Thomas E Wittum, et al.
Plos One|October 18, 2023
Maternal hepatitis C virus infection and three adverse maternal outcomes in the United StatesRobert B Hood, William C Miller, Abigail Shoben, et al.
Maternal and Child Health Journal|May 22, 2023
Maternal Hepatitis C Virus Infection and Adverse Newborn Outcomes in the USRobert B Hood, William C Miller, Abigail Shoben, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Oncology Reports|June 18, 2002
Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokersRandall E Harris, Joanne Beebe-Donk, Hildegard M Schuller
World Journal of Clinical Oncology|October 11, 2014
Cyclooxygenase-2 and the inflammogenesis of breast cancerRandall E Harris, Bruce C Casto, Zachary M Harris
Frontiers in Oncology|January 22, 2026
Vaping, smoking and risk of early onset lung cancerMarisa A Bittoni, David P Carbone, Randall E Harris
International Journal of Biological Sciences|June 26, 2007
Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
BMC Cancer|August 16, 2008
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
Sub-Cellular Biochemistry|July 7, 2007
Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studiesRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
Oncology Reports|March 10, 2005
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)Randall E Harris, Joanne Beebe-Donk, Hani Doss, et al.
Infection Control and Hospital Epidemiology|July 14, 2009
Colonization with Staphylococcus aureus and methicillin-resistant S. aureus among a sample of homeless individuals, OhioTimothy F Landers, Randall E Harris, Thomas E Wittum, et al.
Plos One|October 18, 2023
Maternal hepatitis C virus infection and three adverse maternal outcomes in the United StatesRobert B Hood, William C Miller, Abigail Shoben, et al.
Maternal and Child Health Journal|May 22, 2023
Maternal Hepatitis C Virus Infection and Adverse Newborn Outcomes in the USRobert B Hood, William C Miller, Abigail Shoben, et al.
Pageof 4